Thiadiazinones are cardiotonic agents that have potent, direct, and stereoselective actions on the myofilament response to Ca2' in intact myocardium. Their mechanism of action is unknown. We studied the effects of racemic thiadiazinone, EMD 53998 (5-[1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydro-6-quinolyl]-6-methyl-3,6-dihydro-2H-1,3,4-thiadiazin-2-one), and its enantiomers on Ca21 signaling in myocytes, myofilaments, and myofilament proteins. Intact canine ventricular myocytes responded to the positive enantiomer, EMD 57033, with an increase in the extent of shortening during twitch contractions without increasing the peak amplitude of the Ca2' transient. The negative enantiomer, EMD 57439, also increased the extent of shortening, but in this case there was a concentration-dependent increase in the peak amplitude of the Ca21 transient. This is predicted from in vitro data showing that this enantiomer is a relatively potent inhibitor of phosphodiesterase activity. There was no effect of EMD 57439 on the relation between pCa and actomyosin Mg-ATPase activity of canine heart myofibrils. In contrast, EMD 57033 shifted the pCa-Mg-ATPase activity relation to the left. There was no effect of either enantiomer on Ca2' binding to myofilament troponin C. Moreover EMD 57033, but not EMD 57439, stimulated actomyosin ATPase activity of myofilament preparations in which either troponin or troponin-tropomyosin had been extracted. EMD 57033 had no effect on Mg-ATPase activity of pure ventricular myosin. EMD 57033 also stimulated the velocity of actin filament sliding on myosin heads adhered to nitrocellulose-coated glass coverslips. We propose that the action of EMD 57033 is at the actin-myosin interface on a "'receptor" that may be on actin or the crossbridge. Drug binding to this domain appears to reverse the inhibition of actin-myosin interactions by troponin-tropomyosin and also to promote transition of crossbridges from weak to strong force-generating states. (Circ Res. 1993;73:981-990 case with other chemical classes that have Ca2'-sensitizer activity, some thiadiazinone derivatives also act as inhibitors of phosphodiesterase (PDE).4-7 However, the thiadiazinones have properties that set them apart from other Ca2+ sensitizers. Their effects are greater and occur at concentrations far below those required of other agents with actions as Ca2+ sensitizers, such as sulmazole8 and pimobendan.9 Moreover, in the case of the thiadiazinones, PDE inhibition can be separated from Ca2+ sensitization by minor structural changes in the molecule.4-7 In fact, in the case of EMD 53998, it is now clear from earlier reports5-7 and from results we show here that the Ca2'-sensitizing and PDE inhibitory activity are properties of enantiomers derived from racemic EMD 53998. EMD 57033, the positive enantiomer is effective as a Ca2+ sensitizer, whereas EMD 57439, the negative enantiomer, is not. EMD 57439 is 10 times more effective than EMD 57033 in its action as a PDE inhibitor5 and thus is most likely responsible for the bulk of the PDE inhibitory action of the racemic mixture.
53998 (5-[1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydro-6-quinolyl]-6-methyl-3,6-dihydro-2H-1,3,4-thiadiazin-2-one) and its optical isomers. These agents, developed by Pharmaceutical Research at E. Merck, Darmstadt, Germany,1 belong to a chemical class that acts as so-called "myofilament Ca2`sensitizers."'1-4 Thiadiazinone derivatives, including EMD 53998, at concentrations in the micromolar range, increase contraction amplitude in intact myocardium with no increase in the peak amplitude of the Ca2`transient in most instances. 2 4 In vitro, they act directly on the myofilaments to increase force and actomyosin Mg-ATPase activity by increasing the myofilament response to Ca 2.4,5As is the tizer activity, some thiadiazinone derivatives also act as inhibitors of phosphodiesterase (PDE).4-7 However, the thiadiazinones have properties that set them apart from other Ca2+ sensitizers. Their effects are greater and occur at concentrations far below those required of other agents with actions as Ca2+ sensitizers, such as sulmazole8 and pimobendan.9 Moreover, in the case of the thiadiazinones, PDE inhibition can be separated from Ca2+ sensitization by minor structural changes in the molecule. [4] [5] [6] [7] In fact, in the case of EMD 53998, it is now clear from earlier reports5-7 and from results we show here that the Ca2'-sensitizing and PDE inhibitory activity are properties of enantiomers derived from racemic EMD 53998. EMD 57033, the positive enantiomer is effective as a Ca2+ sensitizer, whereas EMD 57439, the negative enantiomer, is not. EMD 57439 is 10 times more effective than EMD 57033 in its action as a PDE inhibitor5 and thus is most likely responsible for the bulk of the PDE inhibitory action of the racemic mixture.
In view of the potency and selectivity of the Ca2'-sensitizing activity of these compounds, it is important to know how they work. As yet, however, there is no clear evidence on their mechanism of action. Apart from their potential as clinically useful inotropic agents, an understanding of the mechanism of action may lead to their use as probes of domains important in the activation of myofilament proteins. They could work at one or more of the many steps in the cascade of reactions by which Ca2' activates the myofilaments. 10 These include (1) Ca2`binding to troponin (Tn) C, (2) steps in the process by which this signal reverses the inhibitory activity of TnI, TnT, and tropomyosin (Tm) on the actin-myosin crossbridge reaction, and (3) a direct effect on either the actin filament or the crossbridge itself. Results of experiments reported here indicate that the mechanism of the Ca`-sensitizing activity of these agents involves a site on the thin filament important in the transduction of the Ca2+-binding signal rather than on the Ca2`receptor (TnC).
In addition, in the absence of Tn-Tm, the positive enantiomer affects the kinetics of the actomyosin crossbridge cycle, whereas the negative enantiomer does not.
Materials and Methods Materials
The racemic compound EMD 53998 and its enantiomers were synthesized and purified as previously de- scribed' at the Chemical Department of the Pharmaceutical Research Division of E. Merck, Darmstadt, Germany. The purity of the enantiomers was confirmed to be >99%. Stock solutions of the drugs were made in dimethyl sulfoxide (DMSO) at a concentration of 10 mmol/L and prepared fresh on the day of the experiments. All experiments contained an equivalent amount of vehicle, although pilot experiments showed that DMSO had no effect on measured myofilament activities. Pilot experiments also showed that the thiadiazinones used here had no Myofilament preparations. Myofibrils and skinned fibers were extracted from ventricular muscle obtained from canine hearts. After deep anesthesia with intravenous pentobarbital, the hearts were rapidly removed, placed in ice-cold saline, and cleaned free of atria and connective tissue. Left ventricular tissue was used for preparation of cardiac myofibrils as described by Solaro et al12 except for the addition of proteolytic enzyme inhibitors pepstatin (0.5 ,ig/mL), leupeptin (0.5 ,ugl mL), and phenylmethylsulfonyl fluoride (0.2 mmol/L) at all steps of the isolation. Myofibrils lacking Tn-Tm (desensitized myofibrils) were prepared as described previously'3 by a method modified from that described by Lehman.14 Isolated myofibrils were washed extensively and dialyzed against a buffer containing (mmol/L) dithiothreitol, 1; NaN3 0.1; and Tris, 5 (pH 8.0); along with proteolytic enzyme inhibitors as described above. Myofibrils lacking TnC were prepared as previously described'5 using a method modified from that reported by Morimoto and Ohtsuki. 16 The myofibrils were extracted at 25°C, pH 7.8, in (mmol/L) CDTA (trans-1,2-diaminocyclo-hexane-N,N,N'N'-tetraacetic acid), 5; Tris buffer, 40; 3-mercapto ethanol, 15; and sodium azide, 0.6; along with proteolytic enzyme inhibitors as described above. The extraction was done at a protein concentration of approximately 0.25 mg/mL for 15 minutes, after which the myofibrillar suspension was centrifuged at 5000g for 15 minutes. The extraction was repeated (usually three times) until the ATPase activity was independent of free Ca2' concentration and essentially that of relaxed myofibrils. The myofibrils lacking TnC were washed three times in standard buffer (mmol/L: KCl, 60; imidazole, 30; and MgCl2, 2) by centrifugation and resuspension to remove CDTA. Reconstitution was carried out by mixing the TnC-free myofibrils with pure beef cardiac TnC in a 1:1 weight ratio for 60 minutes or longer in the standard buffer. Myosin was prepared from ventricular muscle using the method of Shiverick et al. 17 Extraction of TnC and Tn-Tm and reconstitution was verified by determination of dependence of ATPase rate on Ca 2± and by analyzing the preparations by polyacrlyamide gel electrophoresis as previously described. 15 Detergent-extracted (skinned) fibers. Skinned fibers were prepared from trabeculae cordis of canine left ventricle as described by Pan and Solaro.18 Thin-fiber bundles were first extracted at 4°C in a relaxing solution containing 1% Triton X-100, 10 mmol/L creatine phosphate, 10 U/mL creatine kinase, 3 ,uCi/mL 45Ca, 3 Samples were assayed for 45Ca and 'H, and bound Caẁ as computed from the ratio of 45Ca and 'H in the binding solution and the elution solution. Protein concentration of the myofibrillar preparations and skinned fibers was determined as previously described.18
ATPase rate. Ca'+-dependent Mg-ATPase activity of the various myofibrillar preparations was measured as previously described13 by determination of inorganic phosphate release during a 10-minute incubation at 30°C. Other conditions were as follows (mmol/L): imidazole, 60; Mg-ATP', 5; Mg2+, 2; and ionic strength, 120. Ca2' concentration was varied over a broad pCa (negative log of the molar free Ca'+ concentration) range, and assays were run at pH 7.0. Total concentrations of CaCl2, EGTA, KCI, MgCl2, and ATP were calculated as previously described. 18 The same assay conditions were used for determination of myosin MgATPase rate. The myofibrillar preparations and myosin were preincubated with solvent and drugs for 5 minutes. The reactions were started with ATP and stopped with ice-cold 10% trichloroacetic acid. The precipitate was removed by centrifugation, and inorganic phosphate in the supernatant fraction was determined as described by Carter and Karl.20 In vitro motility assay. Motility assays were performed as previously described.21 '22 Monomeric cardiac myosin (250 ,ug/mL) from heart muscle was adhered to a nitrocellulose-coated glass coverslip. The coverslip was part of a microchamber that was placed on the stage of an inverted microscope, which was equipped for rhodamine epifluorescence and low light level video imaging. Unregulated actin filaments from chicken pectoralis were labeled with tetramethylrhodamine (TRITC-phalloidin) and allowed to interact with the myosin-coated surface in the presence of 1 mmol/L Mg-ATP and various concentrations of the thiadiazinones. All experiments were performed at 20°C. The velocity of actin filament sliding was determined by computer analysis of digitized video images as previously described. 21 (Fig 1A) and for the positive enantiomer (Fig 1B) . The upper portion of each panel in Fig 1 shows indo 1 fluorescence, (Fig 2A) , and of EMD 57033, the positive enantiomer (Fig 2B) Fig 1A with 1B) . In contrast, there appears to be a small decrease in the peak amplitude of
A.
. (Fig 8) . 4.5 increase in the kinetics of the actin-myosin reaction, is demonstrated by results with actomyosin ATPase rate and movement of actin filaments on myosin. Below, we discuss these effects separately as they relate to our proposed mechanism of action of the thiadiazinones.
Ca 2+ Sensitization
Our results with intact canine heart myocytes on the effects of EMD 53998 and its enantiomers agree with data from earlier studies using rat, guinea pig, and ferret myocardial preparations.1-4 These reports have indicated that the thiadiazinones are unique and poten- tially important compounds that apparently react with and stimulate activity of cardiac myofilaments in situ in preparations from intact heart and in isolated cells. Using either aequorin luminescence3 or indo 1 fluorescence3423 as measures of Ca`i, these studies showed that, in the appropriate range of concentrations, the racemic mixture (EMD 53998) can increase the ability of myocardium to shorten and develop force with little 1 which demonstrate differential actions of the enantiomers of EMD 53998 on Ca2t, in canine heart myocytes.
The increase in the Ca2t, transient amplitude, the decrease in its duration, and the decrease in duration of contraction are effects that would be expected to result from an elevation of cAMP. 4 The prolongation of the contraction duration and reduction in diastolic cell length ( Fig 1A) are effects expected to result from myofilament Ca2' sensitization.34
The stereoselectivity of the effect of the thiadiazinones on activation of isolated myofilaments provides strong evidence that the agents affect a specific domain important in determining the state of activation of the myofilaments. Understandably, it has been proposed that this domain is on TnC and that the mechanism of the Ca 2+ sensitization might involve an effect on Ca2+ binding to TnCl-4 Lee and Allen3 based this proposal on a computer model of Ca2+ flux in the myocyte. When the affinity of TnC was increased, calculated values showed a small fall in the peak of the Ca2+ transient, an effect generally attributed to enhanced Ca2+ buffering by the myofilaments. However, in testing this idea by direct measurements on isolated myofilament preparations, our results (Fig 5) show no effects of the racemic mixture or its enantiomers on Ca2+ binding to myofilament TnC at concentrations that significantly increased myofilament activity. Moreover, actin-myosin interactions could be increased by EMD 57033 in preparations without TnC. Therefore, Ca2+ sensitization by the positive thiadiazinone enantiomer appears to involve a myofilament domain other than TnC itself. Based on our observations, it is apparent that the thiadiazinones are able to reverse the inhibition of the actin-myosin interaction by Tn-Tm and also to promote the reaction of myosin with actin. Our hypothesis is that these effects involve a site of binding of EMD at the actin-myosin interface. One consequence of the action of EMD could be to increase the probability of the actin-myosin interaction at a given pCa value. This seems to explain the leftward shift of the pCa-ATPase activity curves seen at a concentration of 10 ,umol/L EMD 57033 in Fig 3C. Another consequence of the action of EMD could be to affect the disinhibition of the myofilaments by strongly bound crossbridges and, in this way, to ease 
Actin-Myosin Reaction
Our studies on desensitized myofibrils and on preparations of pure myosin and actin filaments show strong evidence that EMD acts to stimulate turnover of the actin-crossbridge reaction in a stereoselective manner. In addition, the effect of EMD on maximum ATPase rate of regulated myofilaments at saturating levels of free Ca 2+ could also be due to an action of the drug on the kinetics of the actomyosin ATPase. Results of experiments using the motility assay provide a direct demonstration that EMD affects the turnover of the actin-crossbridge.
How do effects of EMD on the kinetics of the actin-myosin reaction relate to its Ca2+-sensitizing activity? First of all, a relation between the two activities is indicated by the same stereoselectivity of the two effects. Moreover, it is clear that reversal of thinfilament inhibition by EMD can occur without TnC present (Fig 5) . Our hypothesis is that binding of EMD to a site at the actin-myosin interface promotes the reaction of myosin with the thin filament in such a way that actin filament sliding is enhanced and ATPase rate is increased without the thin-filament regulatory complex, whereas in fully regulated myofilaments loss of inhibition by Tn-Tm and disinhibition by strong binding crossbridges is enhanced. Leijendekker and Herzig30 also suggested that an effect of EMD 53998 on the rate constants of the actin-myosin reaction could explain the altered myofilament response to Ca 2+. However, this effect, which was an apparent decrease in the rate of the actin-crossbridge reaction, was present only at levels of Ca2' associated with less than 10% of maximum activity and thus was present only over a narrow range of activation of their preparations. In the case of the motility assay, it is difficult to know exactly which rate constants are affected by EMD, but it does appear that there are differences between fully regulated isometrically contracting fiber bundles and unloaded preparations represented in the motility assay and the assay of myofibrillar ATPase activity. Interestingly, our proposed mechanism of action of EMD 53998 is opposite that which occurs on elevation of inorganic phosphate surrounding the myofilaments, in which case the probability of strongly bound crossbridge attachments is decreased. 25 
